[
  {
    "date": "2023-12-30",
    "symbol": "SPRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Spruce Biosciences, Inc.",
    "entitycentralindexkey": 1683553,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "SPRB",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39594",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-2154263",
    "entityaddressaddressline1": "611 Gateway Boulevard",
    "entityaddressaddressline2": "Suite 740",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 415,
    "localphonenumber": "655-4168",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "BDO USA, P.C.",
    "auditorlocation": "San Jose, California",
    "auditorfirmid": 243,
    "cashandcashequivalentsatcarryingvalue": 96339000,
    "prepaidexpensecurrent": 3876000,
    "otherassetscurrent": 1968000,
    "assetscurrent": 102183000,
    "leaserightofuseasset": 1181000,
    "otherassetsnoncurrent": 582000,
    "assets": 103946000,
    "accountspayablecurrent": 3332000,
    "accruedexpensesandothercurrentliabilities": 14600000,
    "longtermdebtcurrent": 1622000,
    "deferredrevenuecurrent": 4911000,
    "liabilitiescurrent": 24465000,
    "operatingleaseliabilitynoncurrent": 1019000,
    "longtermdebtnoncurrent": 1717000,
    "otherliabilitiesnoncurrent": 236000,
    "liabilities": 27437000,
    "commonstockvalue": 4000,
    "additionalpaidincapitalcommonstock": 273737000,
    "retainedearningsaccumulateddeficit": -197232000,
    "stockholdersequity": 76509000,
    "liabilitiesandstockholdersequity": 103946000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 41029832,
    "commonstocksharesoutstanding": 41029832,
    "revenues": 10089000,
    "researchanddevelopmentexpense": 49432000,
    "generalandadministrativeexpense": 12650000,
    "operatingexpenses": 62082000,
    "operatingincomeloss": -51993000,
    "interestexpense": 483000,
    "interestandotherincome": 4557000,
    "netincomeloss": -47919000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 558000,
    "comprehensiveincomenetoftax": -47361000,
    "earningspersharebasic": -1.24,
    "earningspersharediluted": -1.24,
    "weightedaveragenumberofsharesoutstandingbasic": 38510220,
    "weightedaveragenumberofdilutedsharesoutstanding": 38510220,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 54,
    "exerciseofprefundedwarrants": 8000,
    "exerciseofprefundedwarrantsshares": 800000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 169000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 162791,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": -311000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 349983,
    "stockissuedduringperiodsharesofcommonstockandwarrants": 16116000,
    "stockissuedduringperiodvalueofcommonstockandwarrants": 1000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4622000,
    "commonstockandwarrantnetofferingcosts": 2721000,
    "profitloss": -47919000,
    "sharebasedcompensation": 4622000,
    "depreciationandamortization": 70000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 636000,
    "noncashleaseexpense": 230000,
    "lossondisposalofpropertyandequipment": 2000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2636000,
    "increasedecreaseinotheroperatingassets": -96000,
    "increasedecreaseinaccountspayable": 1906000,
    "increasedecreaseinaccruedliabilities": 6255000,
    "increasedecreaseindeferredrevenue": 4911000,
    "increasedecreaseinotheroperatingliabilities": -176000,
    "netcashprovidedbyusedinoperatingactivities": -33275000,
    "proceedsfromsalematurityandcollectionsofinvestments": 67665000,
    "paymentstoacquireinvestments": 11881000,
    "paymentstoacquirepropertyplantandequipment": 7000,
    "netcashprovidedbyusedininvestingactivities": 55777000,
    "proceedsfromissuanceofcommonstockandwarrants": 53616000,
    "proceedsfromstockplans": 169000,
    "proceedsfromwarrantexercises": 8000,
    "proceedsfromstockoptionsexercised": 1000,
    "paymentsofstockissuancecosts": 2721000,
    "repaymentsoflongtermdebt": 1622000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 311000,
    "netcashprovidedbyusedinfinancingactivities": 49140000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 71642000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 96374000,
    "restrictedcashnoncurrent": 35000,
    "interestpaidnet": 369000,
    "deferredofferingcostsincludedinaccruedexpenses": 51000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 11000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": 33300000,
    "cashcashequivalentsandshortterminvestments": 96300000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 35000,
    "thresholdpercentageoftaxpositionslikelyofbeingrealizeduponultimatesettlement": 0.5,
    "lessoroperatingleaserenewalterm": "P12M",
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember",
    "availableforsaledebtsecuritiesamortizedcostbasis": 95875000,
    "availableforsalesecuritiesdebtsecurities": 95875000,
    "debtinstrumentfairvalue": 3600000,
    "accruedresearchanddevelopmentexpenses": 10832000,
    "accruedemployeebenefitscurrent": 3101000,
    "accruedgeneralandadministrativeexpenses": 416000,
    "leaseliabilitycurrent": 251000,
    "operatingleasecost": 337000,
    "operatingleasepayments": 251000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 343000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 354000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 365000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 376000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 64000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1502000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 232000,
    "operatingleaseliability": 1270000,
    "operatingleaseliabilitycurrent": 251000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.sprucebiosciences.com/20231231#AccruedExpensesAndOtherCurrentLiabilities",
    "longtermdebt": 3713000,
    "debttotalavailable": 30000000,
    "debtavailablefirsttranche": 20000000,
    "debtavailablesecondtranche": 10000000,
    "debtinstrumentmaturitydate": "2022-12-31",
    "debtinstrumentinterestratepercentagescenarioone": 0.005,
    "debtinstrumentinterestratestatedpercentage": 0.09,
    "debtinstrumentinterestratepercentagescenariotwo": 0.0375,
    "numberofmonthlyinstallments": 37,
    "endoftermpaymentamount": 300000,
    "endoftermpaymentpercentage": 0.06,
    "debtinstrumentprepaymentfeepercentage": 0.01,
    "deferredfinancecostsgross": 3400000,
    "unamortizeddebtissuanceexpense": 39000,
    "debtinstrumentcarryingamount": 3300000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1863000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 1714000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 136000,
    "debtinterest": 335000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 39000,
    "potentialadditionalpayment": 23000000,
    "upfrontpayments": 15000000,
    "potentialadditionalcashreceipt": 65000000,
    "commonstockvotingrights": "one vote",
    "commonstockcapitalsharesreservedforfutureissuance": 12687000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "Following the effectiveness of the 2020 Plan, no further grants will be made under the 2016 Plan; however, shares subject to awards granted under the 2016 Plan will continue to be governed by the 2016 Plan.",
    "percentageofincentivestockoptionsgranted": 1,
    "percentageofexercisepriceofincentivestockoptionsgrantedownsstock": 0.1,
    "incentivestockoptionsgranteddescription": "Board of Directors determines the per share exercise price of each stock option, which for ISOs shall not be less than 100% of the fair market value of a share on the date of grant; provided that the exercise price of an ISO granted to a stockholder who at the time of grant owns stock representing more than 10% of the voting power of all classes of stock (a 10% stockholder) shall not be less than 110% of the fair market value of a share on the date of grant.",
    "fairmarketvalueexercisepricepercentage": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.02083,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 2375250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumterm": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsterminationtermifoptionholdersserviceterminate": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 3972376,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 4000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 10200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 77631,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.65,
    "employeestockpurchaseplanofferingperiod": "provides for 24-month offering periods starting every January 1st and July 1st, each consisting of four six-month purchase periods",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 6800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4097376,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 270000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 338764,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 2622154,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.19,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.07,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3050000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3050000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 2249000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 3482663,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 484152,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 404563,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.878,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.037,
    "allocatedsharebasedcompensationexpense": 1547000,
    "valuationallowancedeferredtaxassetchangeinamount": 16800000,
    "operatinglosscarryforwards": 118200000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "taxcreditcarryforwardamount": 22200000,
    "taxcreditcarryforwardexpirationyear": 2036,
    "unrecognizedtaxbenefits": 3200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.053,
    "effectiveincometaxratereconciliationtaxcredits": 0.238,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.008,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.35,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.037,
    "deferredtaxassetsoperatinglosscarryforwards": 33400000,
    "deferredtaxassetscapitalizedresearchandexperimentalcosts": 11744000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 626000,
    "deferredtaxassetsgoodwillandintangibleassets": 77000,
    "deferredtaxassetstaxcreditcarryforwards": 20292000,
    "deferredtaxassetsoperatingleaseliability": 267000,
    "deferredtaxassetsother": 991000,
    "deferredtaxassetsgross": 67397000,
    "deferredtaxassetsvaluationallowance": 67148000,
    "deferredtaxassetsnet": 249000,
    "deferredtaxliabilitiesrightofuseassets": 248000,
    "deferredtaxliabilitiesother": 1000,
    "deferredincometaxliabilities": 249000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 956000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 1520000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 2195000,
    "definedcontributionplanadministrativeexpenses": 100000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 12687000
  },
  {
    "date": "2022-12-30",
    "symbol": "SPRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Spruce Biosciences, Inc.",
    "entitycentralindexkey": 1683553,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "true",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "SPRB",
    "securityexchangename": "Nasdaq Global Select Market",
    "entityfilenumber": "001-39594",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "81-2154263",
    "entityaddressaddressline1": "611 Gateway Boulevard",
    "entityaddressaddressline2": "Suite 740",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 415,
    "localphonenumber": "655-4168",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "BDO USA, LLP",
    "auditorlocation": "Las Vegas, Nevada",
    "auditorfirmid": 243,
    "cashandcashequivalentsatcarryingvalue": 24487000,
    "shortterminvestments": 54590000,
    "prepaidexpensecurrent": 3320000,
    "otherassetscurrent": 1211000,
    "assetscurrent": 83608000,
    "operatingleaserightofuseasset": 1400000,
    "otherassetsnoncurrent": 640000,
    "assets": 85648000,
    "accountspayablecurrent": 1426000,
    "accruedexpensesandothercurrentliabilities": 9399000,
    "longtermdebtcurrent": 1622000,
    "liabilitiescurrent": 12447000,
    "operatingleaseliabilitynoncurrent": 1261000,
    "longtermdebtnoncurrent": 3293000,
    "otherliabilitiesnoncurrent": 161000,
    "liabilities": 17162000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 218354000,
    "accumulatedothercomprehensiveincomelossnetoftax": -558000,
    "retainedearningsaccumulateddeficit": -149313000,
    "stockholdersequity": -149313000,
    "liabilitiesandstockholdersequity": 85648000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 35198000,
    "generalandadministrativeexpense": 12085000,
    "operatingexpenses": 47283000,
    "operatingincomeloss": -47283000,
    "interestexpense": 420000,
    "interestandotherincome": 1523000,
    "netincomeloss": -46180000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -374000,
    "comprehensiveincomenetoftax": -46554000,
    "earningspersharebasic": -1.96,
    "earningspersharediluted": -1.96,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 2000,
    "stockissuedduringperiodsharesstockoptionsexercised": 992,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 76000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 66299,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": -40000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 41832,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3631000,
    "profitloss": -46180000,
    "sharebasedcompensation": 3631000,
    "depreciationandamortization": 74000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -16000,
    "operatingleaserightofuseassetamortizationexpense": 355000,
    "gainlossonterminationoflease": 800000,
    "gainlossonsaleofpropertyplantequipment": -39000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 817000,
    "increasedecreaseinotheroperatingassets": -90000,
    "increasedecreaseinaccountspayable": -1397000,
    "increasedecreaseinaccruedliabilities": 3587000,
    "increasedecreaseinothernoncurrentliabilities": -331000,
    "netcashprovidedbyusedinoperatingactivities": -41683000,
    "proceedsfromsalematurityandcollectionsofinvestments": 60500000,
    "paymentstoacquireinvestments": 36800000,
    "paymentstoacquirepropertyplantandequipment": 8000,
    "netcashprovidedbyusedininvestingactivities": 23692000,
    "proceedsfromstockoptionsexercised": 2000,
    "proceedsfromstockplans": 76000,
    "paymentsofdeferredofferingcosts": 279000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 40000,
    "netcashprovidedbyusedinfinancingactivities": -241000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -18232000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 24732000,
    "restrictedcashcurrent": 216000,
    "restrictedcashnoncurrent": 29000,
    "interestpaidnet": 266000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1418000,
    "deferredofferingcostsincludedinaccruedexpenses": 53000,
    "paymentsofdebtissuancecosts": 10000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": 41700000,
    "cashcashequivalentsandshortterminvestments": 79100000,
    "upfrontpaymentreceived": 15000000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 200000,
    "thresholdpercentageoftaxpositionslikelyofbeingrealizeduponultimatesettlement": 0.5,
    "lessoroperatingleaserenewalterm": 12,
    "propertyplantandequipmentusefullife": "7 years",
    "propertyplantandequipmentestimatedusefullives": "Lesser of lease term of 15 years",
    "cashandcashequivalentsfairvaluedisclosure": 22496000,
    "availableforsalesecuritiesdebtsecurities": 77086000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 77644000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 559000,
    "debtinstrumentfairvalue": 4900000,
    "accruedinvestmentincomereceivable": 100000,
    "cashequivalentsandshortterminvestmentsdueterm": "one year",
    "weightedaverageremainingcontractualtermmaturitiesavailableforsale": "4 months",
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 16743000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 77000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 34911000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 482000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 51654000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 559000,
    "accruedresearchanddevelopmentexpenses": 7449000,
    "accruedemployeebenefitscurrent": 1286000,
    "accruedgeneralandadministrativeexpenses": 525000,
    "operatingleaseliabilitycurrent": 139000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.sprucebiosciences.com/20221231#AccruedExpensesAndOtherCurrentLiabilities",
    "accruedliabilitiesandotherliabilitiescurrent": 9399000,
    "landsubjecttogroundleases": 6500,
    "operatingleasecommencementmonthandyear": "December 2022",
    "operatingleaseterminationmonthandyear": "February 2028",
    "operatingleasesterminationagreement": "November 28, 2022",
    "operatingleasesfutureminimumpaymentsdue": 1700000,
    "lesseeoperatingleaseoptiontoextend": "The Company has an option to extend the lease term of the South San Francisco Lease for an additional three years which has not been included in the lease term as it is not reasonably certain that the Company will exercise this option.",
    "lesseeoperatingleaserenewalterm": "three years",
    "letterofcreditissued": 29000,
    "unrecognizedcashdepositcollateral": 29000,
    "operatingleasecost": 465000,
    "operatingleasepayments": 492000,
    "operatingleaseweightedaverageremainingleaseterm1": 5.2,
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 249000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 341000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 351000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 362000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 373000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 64000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1740000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 340000,
    "operatingleaseliability": 1400000,
    "longtermdebt": 5642000,
    "debttotalavailable": 30000000,
    "debtavailablefirsttranche": 20000000,
    "debtavailablesecondtranche": 10000000,
    "debtinstrumentmaturitydate": "January 1, 2026",
    "debtinstrumentinterestratepercentagescenarioone": 0.005,
    "debtinstrumentinterestratestatedpercentage": 0.08,
    "debtinstrumentinterestratepercentagescenariotwo": 0.0375,
    "numberofmonthlyinstallments": 37,
    "endoftermpaymentamount": 300000,
    "endoftermpaymentpercentage": 0.06,
    "debtinstrumentprepaymentfeepercentage": 0.02,
    "deferredfinancecostsgross": 5000000,
    "unamortizeddebtissuanceexpense": 100000,
    "lineofcreditfacilitycurrentborrowingcapacity": 10000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1966000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 1836000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1704000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 136000,
    "debtinterest": 642000,
    "debtinstrumentcarryingamount": 5000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 85000,
    "commonstockvotingrights": "one vote",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "In addition, the number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first ten-years of the term of the ESPP, beginning with January 1, 2021 and ending with ",
    "percentageofincentivestockoptionsgranted": 1,
    "percentageofexercisepriceofincentivestockoptionsgrantedownsstock": 0.1,
    "incentivestockoptionsgranteddescription": " Board of Directors determines the per share exercise price of each stock option, which for ISOs shall not be less than 100% of the fair market value of a share on the date of grant; provided that the exercise price of an ISO granted to a stockholder who at the time of grant owns stock representing more than 10% of the voting power of all classes of stock (a 10% stockholder) shall not be less than 110% of the fair market value of a share on the date of grant.",
    "fairmarketvalueexercisepricepercentage": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 126713,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumterm": "five years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 140000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 601819,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.34,
    "employeestockpurchaseplanofferingperiod": "provides for 24-month offering periods starting every January 1st and July 1st, each consisting of four six-month purchase periods",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 7200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 860131,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.38,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.39,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 4.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 52000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 52000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 52000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 113284,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 168788,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 2.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.772,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.022000000000000002,
    "allocatedsharebasedcompensationexpense": 3631000,
    "clinicalandsalesmilestonespayments": 23000000,
    "valuationallowancedeferredtaxassetchangeinamount": 17000000,
    "operatinglosscarryforwards": 141100000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "taxcreditcarryforwardamount": 1200000,
    "taxcreditcarryforwardexpirationyear": 2036,
    "unrecognizedtaxbenefits": 3000000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.07,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.005,
    "effectiveincometaxratereconciliationtaxcredits": 0.08900000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.364,
    "deferredtaxassetsoperatinglosscarryforwards": 33871000,
    "deferredtaxassetscapitalizedresearchandexperimentalcosts": 5559000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 369000,
    "deferredtaxassetsgoodwillandintangibleassets": 116000,
    "deferredtaxassetstaxcreditcarryforwards": 8878000,
    "deferredtaxassetsoperatingleaseliability": 392000,
    "deferredtaxassetsother": 1568000,
    "deferredtaxassetsgross": 50753000,
    "deferredtaxassetsvaluationallowance": 50359000,
    "deferredtaxassetsnet": 394000,
    "deferredtaxliabilitiesrightofuseassets": 392000,
    "deferredtaxliabilitiesother": 2000,
    "deferredincometaxliabilities": 394000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1433000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 63000,
    "definedcontributionplanadministrativeexpenses": 100000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "SPRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Spruce Biosciences, Inc.",
    "entitycentralindexkey": 1683553,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "true",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "SPRB",
    "securityexchangename": "Nasdaq Global Select Market",
    "entityfilenumber": "001-39594",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "81-2154263",
    "entityaddressaddressline1": "2001 Junipero Serra Boulevard",
    "entityaddressaddressline2": "Suite 640",
    "entityaddresscityortown": "Daly City",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94014,
    "cityareacode": 415,
    "localphonenumber": "655-4168",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "BDO USA, LLP",
    "auditorlocation": "San Jose, California",
    "auditorfirmid": 243,
    "cashandcashequivalentsatcarryingvalue": 42748000,
    "shortterminvestments": 46221000,
    "prepaidexpensecurrent": 2530000,
    "otherassetscurrent": 396000,
    "assetscurrent": 91895000,
    "restrictedcashnoncurrent": 216000,
    "operatingleaserightofuseasset": 1479000,
    "longterminvestments": 32459000,
    "otherassetsnoncurrent": 437000,
    "assets": 126486000,
    "accountspayablecurrent": 2823000,
    "accruedliabilitiesandotherliabilitiescurrent": 4613000,
    "accruedemployeebenefitscurrent": 1435000,
    "liabilitiescurrent": 8871000,
    "longtermdebtnoncurrent": 4878000,
    "operatingleaseliabilitynoncurrent": 1293000,
    "otherliabilitiesnoncurrent": 73000,
    "liabilities": 15115000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 214685000,
    "accumulatedothercomprehensiveincomelossnetoftax": -184000,
    "retainedearningsaccumulateddeficit": -103133000,
    "stockholdersequity": -103133000,
    "liabilitiesandstockholdersequity": 126486000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 30698000,
    "generalandadministrativeexpense": 11368000,
    "operatingexpenses": 42066000,
    "operatingincomeloss": -42066000,
    "interestexpense": 345000,
    "othernonoperatingincomeexpense": 119000,
    "netincomeloss": -42292000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -184000,
    "comprehensiveincomenetoftax": -42476000,
    "earningspersharebasicanddiluted": -1.81,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 328000,
    "stockissuedduringperiodsharesstockoptionsexercised": 211439,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 134000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 20043,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3958000,
    "profitloss": -42292000,
    "sharebasedcompensation": 3958000,
    "depreciationdepletionandamortization": 68000,
    "amortizationofpremiumonavailableforsaleinvestments": 121000,
    "operatingleaserightofuseassetamortizationexpense": 313000,
    "increasedecreaseinprepaidexpensesandothercurrentassets": -415000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1149000,
    "increasedecreaseinemployeerelatedliabilities": 350000,
    "increasedecreaseinotheroperatingassets": -197000,
    "increasedecreaseinotheroperatingliabilities": -156000,
    "netcashprovidedbyusedinoperatingactivities": -35877000,
    "paymentstoacquirepropertyplantandequipment": 93000,
    "paymentstoacquireinvestments": 79075000,
    "netcashprovidedbyusedininvestingactivities": -79168000,
    "proceedsfromissuanceoflongtermdebt": 4990000,
    "repaymentsoflongtermdebt": 4770000,
    "proceedsfromstockoptionsexercised": 328000,
    "proceedsfromstockplans": 134000,
    "paymentsofdeferredofferingcosts": 39000,
    "netcashprovidedbyusedinfinancingactivities": 643000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -114402000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 42964000,
    "interestpaidnet": 207000,
    "deferredofferingcostsincludedinaccruedexpenses": 52000,
    "paymentsofdebtissuancecosts": 10000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": 35900000,
    "cashcashequivalentsandinvestments": 121400000,
    "numberofoperatingsegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "two years",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted ",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "not",
    "restrictedcash": 216000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 42964000,
    "propertyplantandequipmentusefullife": "5 years",
    "propertyplantandequipmentestimatedusefullives": "Lesser of lease term or 15 years",
    "availableforsaledebtsecuritiesamortizedcostbasis": 32607000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 148000,
    "availableforsalesecuritiesdebtsecurities": 32459000,
    "cashandcashequivalentsamortizedcost": 38067000,
    "cashandcashequivalentsfairvaluedisclosure": 38067000,
    "cashandcashequivalentsandavailableforsaleamortizedcost": 116931000,
    "cashandcashequivalentsandavailableforsalegrossunrealizedloss": 184000,
    "cashandcashequivalentsandavailableforsalefairvalue": 33973000,
    "weightedaverageremainingcontractualtermmaturitiesavailableforsale": "11 months",
    "cashequivalentsandshortterminvestmentsdueterm": " one year",
    "debtinstrumentfairvalue": 5000000,
    "propertyplantandequipmentgross": 64000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 31000,
    "propertyplantandequipmentnet": 140000,
    "depreciation": 23000,
    "accruedresearchanddevelopmentexpenses": 3837000,
    "accruedgeneralandadministrativeexpenses": 416000,
    "operatingleaseliabilitycurrent": 360000,
    "lesseeoperatingleaseoptiontoextend": "The lease includes an option to renew the lease term for an additional period of 60 months. The renewal option is not included in the lease term or minimum lease payments disclosures below as the Company is not reasonably certain to exercise the option.",
    "operatingleasecost": 400000,
    "operatingleaseweightedaverageremainingleaseterm1": 3.9,
    "operatingleaseweightedaveragediscountratepercent": 0.07,
    "cashpaidforamountsincludedinmeasurementofleaseliabilities": 300000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 464000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 478000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 493000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 464000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1899000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 246000,
    "operatingleaseliability": 1653000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.sprucebiosciences.com/20211231#AccruedLiabilitiesAndOtherLiabilitiesCurrent",
    "longtermdebt": 4878000,
    "repaymentsofdebt": 5000000,
    "debtinstrumentmaturitydate": "January 1, 2026",
    "debtinstrumentfrequencyofperiodicpayment": "monthly",
    "debtinstrumentbasisspreadvariableratescenarioone": 0.01,
    "debtinstrumentfrequencyofperiodicpaymentscenarioone": 0.0425,
    "debtinstrumentbasisspreadvariableratescenariotwo": 0.03,
    "debtinstrumentfrequencyofperiodicpaymentscenariotwo": 0.0625,
    "numberofmonthlyinstallments": 25,
    "endoftermpaymentpercentage": 0.095,
    "debtinstrumentprepaymentfeepercentage": 0.03,
    "deferredfinancecostsgross": 2000,
    "debtinstrumentunamortizeddebtissuancecostsanddiscount": 100000,
    "debtinstrumentunamortizeddiscount": 16000,
    "interestexpensedebt": 200000,
    "debtinstrumentcarryingamount": 5000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 122000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 1622000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1622000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 1621000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 135000,
    "commonstockvotingrights": "one vote",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "Following the effectiveness of the 2020 Plan, no further grants will be made under the 2016 Plan; however, shares subject to awards granted under the 2016 Plan will continue to be governed by the 2016 Plan.",
    "percentageofincentivestockoptionsgranted": 1,
    "percentageofexercisepriceofincentivestockoptionsgrantedownsstock": 0.1,
    "incentivestockoptionsgranteddescription": "Under the Plan, the Board of Directors determines the per share exercise price of each stock option, which for ISOs shall not be less than 100% of the fair market value of a share on the date of grant; provided that the exercise price of an ISO granted to a stockholder who at the time of grant owns stock representing more than 10% of the voting power of all classes of stock (a 10% stockholder) shall not be less than 110% of the fair market value of a share on the date of grant.",
    "fairmarketvalueexercisepricepercentage": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 460000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumterm": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsterminationtermifoptionholdersserviceterminate": "three months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 127042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 433200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 947917,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.55,
    "employeestockpurchaseplanofferingperiod": "provides for 24-month offering periods starting every January 1st and July 1st, each consisting of four six-month purchase periods",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 2400000,
    "allocatedsharebasedcompensationexpense": 900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 799307,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 961313,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.72,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 6.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 6.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 3.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3959000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3959000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 2209000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.787,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 460000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaveragegrantdatefairvalue": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantedweightedaveragegrantdatefairvalue": 2.48,
    "clinicalandsalesmilestonespayments": 23000000,
    "valuationallowancedeferredtaxassetchangeinamount": 13900000,
    "operatinglosscarryforwards": 98400000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "taxcreditcarryforwardamount": 1000000,
    "taxcreditcarryforwardexpirationyear": 2036,
    "thresholdpercentageoftaxpositionslikelyofbeingrealizeduponultimatesettlement": 0.5,
    "unrecognizedtaxbenefits": 1600000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0698,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0038,
    "effectiveincometaxratereconciliationtaxcredits": 0.053099999999999994,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3296,
    "effectiveincometaxratereconciliationotheradjustments": 0.0005,
    "deferredtaxassetsoperatinglosscarryforwards": 27570000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 99000,
    "deferredtaxassetsgoodwillandintangibleassets": 131000,
    "deferredtaxassetstaxcreditcarryforwards": 4766000,
    "deferredtaxassetsleaseliability": 463000,
    "deferredtaxassetsother": 785000,
    "deferredtaxassetsgross": 33814000,
    "deferredtaxassetsvaluationallowance": 33397000,
    "deferredtaxliabilitiesrightofuseassets": 414000,
    "deferredtaxliabilitiesother": 3000,
    "deferredincometaxliabilities": 417000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 198000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 693000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "restructuringandrelatedactivitiesdescription": "Pursuant to the Separation Agreement, Mr. King was entitled to receive an amount equal to 12 months of his base salary ($500,000 per year), which was paid in a single lump sum payment in January 2022, and continued coverage under COBRA for 12 months. In addition, the Separation Agreement provided that all vested options held by Mr. King as of the separation date be exercisable through June 30, 2023."
  },
  {
    "date": "2020-12-30",
    "symbol": "SPRB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Spruce Biosciences, Inc.",
    "entitycentralindexkey": 1683553,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "SPRB",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39594",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-2154263",
    "entityaddressaddressline1": "2001 Junipero Serra Boulevard",
    "entityaddressaddressline2": "Suite 640",
    "entityaddresscityortown": "Daly City",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94014,
    "cityareacode": 415,
    "localphonenumber": "655-4168",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 157150000,
    "prepaidexpensecurrent": 2971000,
    "otherassetscurrent": 276000,
    "assetscurrent": 160397000,
    "restrictedcashnoncurrent": 216000,
    "operatingleaserightofuseasset": 1793000,
    "otherassetsnoncurrent": 477000,
    "assets": 162883000,
    "accountspayablecurrent": 3628000,
    "longtermdebtcurrent": 2554000,
    "accruedliabilitiesandotherliabilitiescurrent": 2496000,
    "accruedemployeebenefitscurrent": 1085000,
    "liabilitiescurrent": 9763000,
    "longtermdebtnoncurrent": 1922000,
    "operatingleaseliabilitynoncurrent": 1653000,
    "otherliabilitiesnoncurrent": 118000,
    "liabilities": 13456000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 210266000,
    "retainedearningsaccumulateddeficit": -60841000,
    "stockholdersequity": -60841000,
    "liabilitiesandstockholdersequity": 162883000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "temporaryequitysharesauthorized": 73333330,
    "temporaryequitysharesissued": 73333330,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 23260399,
    "commonstocksharesoutstanding": 23260399,
    "researchanddevelopmentexpense": 23854000,
    "generalandadministrativeexpense": 5562000,
    "operatingexpenses": 29416000,
    "operatingincomeloss": -29416000,
    "interestexpense": 323000,
    "othernonoperatingincomeexpense": 200000,
    "netincomeloss": -29539000,
    "earningspersharebasicanddiluted": -4.93,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 5991213,
    "temporaryequitystockissuedduringperiodvaluenewissues": 87633000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 73333330,
    "temporaryequityconvertedintocommonstockvalue": 87633000,
    "temporaryequitysharesconvertedintocommonstock": 73333330,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 115446000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 46358,
    "stockissuedduringperiodvaluenewissues": 93351000,
    "stockissuedduringperiodsharesnewissues": 6900000,
    "stockissuedduringperiodvaluestockoptionsexercised": 51000,
    "stockissuedduringperiodsharesstockoptionsexercised": 57614,
    "stockissuedduringperiodsharesexerciseofwarrants": 46358,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 755000,
    "temporaryequitystockissuancecosts": 367000,
    "underwritingexpensesandofferingcosts": 10149000,
    "profitloss": -29539000,
    "sharebasedcompensation": 755000,
    "depreciationdepletionandamortization": 36000,
    "noncashoperatingleaseexpense": 66000,
    "increasedecreaseinprepaidexpensesandothercurrentassets": 2883000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3733000,
    "increasedecreaseinemployeerelatedliabilities": 177000,
    "increasedecreaseinotheroperatingassets": 6000,
    "increasedecreaseinotheroperatingliabilities": 142000,
    "netcashprovidedbyusedinoperatingactivities": -27519000,
    "paymentstoacquirepropertyplantandequipment": 74000,
    "netcashprovidedbyusedininvestingactivities": -74000,
    "proceedsfromissuanceofredeemableconvertiblepreferredstock": 87633000,
    "proceedsfromissuanceinitialpublicoffering": 96255000,
    "paymentsforrepurchaseofinitialpublicoffering": 2904000,
    "proceedsfromstockoptionsexercised": 51000,
    "netcashprovidedbyusedinfinancingactivities": 181035000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 153442000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 157366000,
    "interestpaidnet": 192000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1858000,
    "conversionofstockamountconverted1": 87633000,
    "stockholdersequityreversestocksplit": "1-for-6.541 basis",
    "convertiblepreferredstocksharesissueduponconversion": 15492019,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": 27500000,
    "numberofoperatingsegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P2Y",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "operatingleaserightofuseassetgross": 1900000,
    "operatingleaseliability": 1902000,
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "restrictedcash": 216000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 157366000,
    "debtinstrumentfairvalue": 4800000,
    "accruedresearchanddevelopmentexpenses": 2002000,
    "accruedgeneralandadministrativeexpenses": 245000,
    "operatingleaseliabilitycurrent": 249000,
    "lesseeoperatingleaseoptiontoextend": "The lease includes an option to renew the lease term for an additional period of 60 months. The renewal option is not included in the lease term or minimum lease payments disclosures below as the Company is not reasonably certain to exercise the option.",
    "operatingleasecost": 100000,
    "lesseeoperatingleaseterminationdate": "2020-05",
    "shorttermleasecost": 100000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y10M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.07,
    "cashpaidforamountsincludedinmeasurementofleaseliabilities": 37000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 377000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 464000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 478000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 493000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 464000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2276000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 374000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "sprb:AccruedLiabilitiesAndOtherLiabilitiesCurrent",
    "longtermdebt": 4476000,
    "debtinstrumentfrequencyofperiodicpayment": "monthly",
    "deferredfinancecostsgross": 8000,
    "debtinstrumentunamortizeddebtissuancecostsanddiscount": 24000,
    "interestexpensedebt": 200000,
    "debtinstrumentcarryingamount": 4500000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 24000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2571000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 1929000,
    "commonstockvotingrights": "one vote",
    "temporaryequityissuepricepershare": 1.2,
    "temporaryequityliquidationpreferencepershare": 1.2,
    "redeemableconvertiblepreferredstockholdersentitledtoreceivegreaterofmaximumparticipationpricepershare": 4.8,
    "temporaryequityconversionpricepershare": 7.849,
    "potentialminimumgrosscashproceedsfromredeemableconvertiblepreferredstock": 50000000,
    "potentialminimumpublicofferingpricepershare": 15.6984,
    "redeemableconvertiblepreferredstockholdersvotingrights": "one vote",
    "numberofdirectorsentitledtobeelected": 1,
    "redeemablepreferredstockdividendsdeclaredpercentage": 0.08,
    "commonstockcapitalsharesreservedforfutureissuance": 5136487,
    "percentageofincentivestockoptionsgranted": 1,
    "percentageofexercisepriceofincentivestockoptionsgrantedownsstock": 0.1,
    "incentivestockoptionsgranteddescription": "Under the Plan, the Board of Directors determines the per share exercise price of each stock option, which for ISOs shall not be less than 100% of the fair market value of a share on the date of grant; provided that the exercise price of an ISO granted to a stockholder who at the time of grant owns stock representing more than 10% of the voting power of all classes of stock (a 10% stockholder) shall not be less than 110% of the fair market value of a share on the date of grant.",
    "fairmarketvalueexercisepricepercentage": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.02083,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsterminationtermifoptionholdersserviceterminate": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 127042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 2268163,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 220640,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 1775808,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 600000,
    "employeestockpurchaseplanofferingperiod": "provides for 24-month offering periods starting every January 1st and July 1st, each consisting of four six-month purchase periods",
    "initialofferingperiod": "October 8, 2020 to December 31, 2022.",
    "allocatedsharebasedcompensationexpense": 755000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 5000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2278771,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 298745,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2132726,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 603963,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.78,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 1.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 49059000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 45965000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 13822000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P2Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.002,
    "clinicalandsalesmilestonespayments": 23000000,
    "valuationallowancedeferredtaxassetchangeinamount": 12200000,
    "operatinglosscarryforwards": 58400000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "taxcreditcarryforwardamount": 600000,
    "taxcreditcarryforwardexpirationyear": 2036,
    "grossfederaltaxcreditrelateddeferredtaxassetsderecognized": 2000,
    "thresholdpercentageoftaxpositionslikelyofbeingrealizeduponultimatesettlement": 0.5,
    "unrecognizedtaxbenefits": 1094000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0698,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0009,
    "effectiveincometaxratereconciliationtaxcredits": 0.0615,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.4138,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.0696,
    "effectiveincometaxratereconciliationotheradjustments": 0.0038,
    "deferredtaxassetsoperatinglosscarryforwards": 16381000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 326000,
    "deferredtaxassetsgoodwillandintangibleassets": 143000,
    "deferredtaxassetstaxcreditcarryforwards": 2500000,
    "deferredtaxassetsother": 109000,
    "deferredtaxassetsgross": 19459000,
    "deferredtaxassetsvaluationallowance": 19459000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 10000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 686000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2302889
  }
]